G1 Therapeutics.

PositionRTP

G1 Therapeutics raised $47 million in a financing led by Boston-based Cormorant Asset Management that included existing investors Eshelman Ventures and Hatteras Venture Partners. The company is developing treatments for lung...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT